Understanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpoints

Survival rates for metastatic lung cancer, including non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), are poor with 5-year survivals of less than 5%. The immune system has an intricate and complex relationship with tumorigenesis; a groundswell of research on the immune system is...

Descripción completa

Detalles Bibliográficos
Autores principales: Karachaliou, Niki, Cao, Maria Gonzalez, Teixidó, Cristina, Viteri, Santiago, Morales-Espinosa, Daniela, Santarpia, Mariacarmela, Rosell, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493378/
https://www.ncbi.nlm.nih.gov/pubmed/26175923
http://dx.doi.org/10.7497/j.issn.2095-3941.2015.0029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493378/
https://www.ncbi.nlm.nih.gov/pubmed/26175923
http://dx.doi.org/10.7497/j.issn.2095-3941.2015.0029

Ejemplares similares